NewAmsterdam Pharma (NAMS) Earnings Date, Estimates & Call Transcripts → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free NAMS Stock Alerts $20.09 +0.04 (+0.20%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (May. 8) -$0.62 Missed By -$0.08 Consensus EPS (May. 8) -$0.54 Get NewAmsterdam Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for NAMS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNAMS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NAMS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… NewAmsterdam Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.55)($0.51)($0.53)Q2 20243($0.57)($0.46)($0.53)Q3 20243($0.47)($0.36)($0.40)Q4 20242($0.41)($0.31)($0.36)FY 202411($2.00)($1.64)($1.82)Q1 20251($0.27)($0.27)($0.27)Q2 20251($0.25)($0.25)($0.25)Q3 20251($0.25)($0.25)($0.25)Q4 20251($0.25)($0.25)($0.25)FY 20254($1.02)($1.02)($1.02)NAMS Earnings Date and InformationNewAmsterdam Pharma last released its earnings data on May 8th, 2024. The reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.54) by $0.08. The business earned $1.40 million during the quarter, compared to the consensus estimate of $2.95 million. NewAmsterdam Pharma has generated $0.00 earnings per share over the last year. Earnings for NewAmsterdam Pharma are expected to grow in the coming year, from ($2.52) to ($1.60) per share. NewAmsterdam Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More NewAmsterdam Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024Estimated)------- 5/8/2024Q1 2024($0.54)($0.62)($0.08)($0.18)$2.95 million$1.40 million NewAmsterdam Pharma Earnings - Frequently Asked Questions When is NewAmsterdam Pharma's earnings date? NewAmsterdam Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on NAMS's earnings history. Did NewAmsterdam Pharma beat their earnings estimates last quarter? In the previous quarter, NewAmsterdam Pharma (NASDAQ:NAMS) missed the analysts' consensus estimate of ($0.54) by $0.08 with a reported earnings per share (EPS) of ($0.62). Learn more on analysts' earnings estimate vs. NAMS's actual earnings. How much revenue does NewAmsterdam Pharma generate each year? NewAmsterdam Pharma (NASDAQ:NAMS) has a recorded annual revenue of $14.09 million. How much profit does NewAmsterdam Pharma generate each year? NewAmsterdam Pharma (NASDAQ:NAMS) has a recorded net income of -$176.94 million. NAMS has generated $0.00 earnings per share over the last four quarters. What is NewAmsterdam Pharma's EPS forecast for next year? NewAmsterdam Pharma's earnings are expected to grow from ($2.52) per share to ($1.60) per share in the next year. More Earnings Resources from MarketBeat Related Companies: SNDX Earnings ARDX Earnings GLPG Earnings KROS Earnings PTGX Earnings AGIO Earnings CPRX Earnings HRMY Earnings SDGR Earnings AMPH Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:NAMS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
